Hydrocodone 10/325mg is a Schedule II controlled substance combining 10mg hydrocodone bitartrate (a potent opioid analgesic) with 325mg acetaminophen (a non-opioid pain reliever). This lower-acetaminophen formulation reduces liver toxicity risks while maintaining effective pain relief, making it one of the most commonly prescribed opioid medications in the United States for acute moderate-to-severe pain management.
Hydrocodone 10-325mg
Hydrocodone 10-325mg is a prescription pain medication that combines 10mg of hydrocodone, a potent opioid, with 325mg of acetaminophen, a non-opioid pain reliever. This combination effectively manages moderate to severe pain, commonly prescribed for conditions like post-surgical recovery, injuries, or chronic pain. Hydrocodone works by altering the brain’s response to pain, while acetaminophen enhances its pain-relieving effects. Due to the opioid content, Hydrocodone 10-325mg should be taken exactly as prescribed by a healthcare provider to avoid risks such as misuse or overdose. Always follow your doctor’s instructions for safe use.
Medical Uses & Indications
FDA-Approved Uses
Acute pain management (Post-surgical, dental procedures, injuries)
Short-term treatment of severe pain (≤14 days typically)
Alternative to higher-acetaminophen formulations (For liver-compromised patients)
Key Clinical Features
• Onset: 20-30 minutes (oral administration)
• Duration: 4-6 hours of analgesia
• DEA Classification: Schedule II (High abuse potential)
• Recommended Treatment Duration: 3-5 days (rarely exceeding 14 days)
Pharmacology & Effects
Mechanism of Action
• Hydrocodone: μ-opioid receptor agonist → pain relief + euphoria
• Acetaminophen: COX inhibitor → pain/fever reduction
Therapeutic Effects
Effective analgesia (30-60 minute onset)
Mild anxiolytic properties
Cough suppression (at lower doses)
Recreational Abuse Potential
• Euphoria (Particularly at supratherapeutic doses)
• Sedation/relaxation
• Psychological dependence risk
Dosing Guidelines
Standard Administration
• Adults: 1 tablet every 4-6 hours PRN pain
• Maximum Daily Limits:
-
Hydrocodone: 40mg (4 tablets)
-
Acetaminophen: 3,250mg (10 tablets)
Special Populations
| Group | Dosing Adjustment |
|---|---|
| Hepatic Impairment | Avoid or reduce dose |
| Renal Impairment (CrCl <30) | 50% dose reduction |
| Elderly | Start with 5mg hydrocodone |
Safety Profile
Common Side Effects (≥1%)
• Constipation (prophylactic stool softeners recommended)
• Nausea/vomiting
• Dizziness/somnolence
• Pruritus (without rash)
Black Box Warnings
Addiction/abuse potential (Even at prescribed doses)
Life-threatening respiratory depression
Accidental ingestion (especially children)
CYP3A4 interactions (Can increase toxicity)
Drug Interactions
Dangerous Combinations
• Benzodiazepines: ↑ Respiratory depression risk
• Alcohol: ↑ CNS depression + liver toxicity
• CYP3A4 Inhibitors: ↑ Hydrocodone levels (e.g., macrolides, azoles)
• MAOIs: Serotonin syndrome risk
Withdrawal Management
Typical Onset Timeline
| Phase | Timeframe | Symptoms |
|---|---|---|
| Early | 6-12 hours | Anxiety, sweating |
| Peak | 24-72 hours | GI distress, tremors |
| Protracted | Weeks | Insomnia, cravings |
Medical Detox Options
• Buprenorphine taper
• Clonidine for symptoms
• Supportive care
Harm Reduction Strategies
-
Prescription monitoring: Use state PDMP systems
-
Naloxone co-prescribing: Mandatory in many states
-
Safe storage: Locked containers
-
Proper disposal: DEA take-back programs
Therapeutic Alternatives
Non-Opioid Options
• NSAID combinations (Ibuprofen 600mg + acetaminophen)
• Duloxetine (For neuropathic pain components)
• Lidocaine patches (Localized pain)
Opioid Alternatives
• Tramadol (Lower schedule)
• Buprenorphine (Partial agonist)
• Tapentadol (Dual mechanism)
Clinical Pearls
• Always assess risk/benefit before prescribing
• Consider ER formulations for chronic pain instead
• Routinely screen for misuse behaviors
• Document thoroughly given litigation risks